Neuland Laboratories is currently trading at Rs 249.95, up by 10.35 points or 4.32% from its previous closing of Rs 239.60 on the BSE.
The scrip opened at Rs 240.00 and has touched a high and low of Rs 252.00 and Rs 221.00 respectively. So far 7159 shares were traded on the counter.
The BSE group 'B' stock of face value Rs 10 has touched a 52 week high of Rs 298.65 on 21-Oct-2013 and a 52 week low of Rs 86.75 on 19-Mar-2013.
Last one week high and low of the scrip stood at Rs 280.00 and Rs 228.00 respectively. The current market cap of the company is Rs 178.82 crore.
The promoters holding in the company stood at 50.07%, while Institutions and Non-Institutions held 0.01% and 49.92% respectively.
Neuland Laboratories has reported 11.68% rise in its net profit at Rs 3.44 crore for the quarter as compared to Rs 3.08 crore for the same quarter in the previous year. However, total income from operation of the company has decreased by 10.97% at Rs 105.09 crore for quarter under review as compared to Rs 118.04 crore for the quarter ended September 30, 2012.
Neuland Laboratories is engaged in manufacturing of Salbutamol Sulphate. The company has has two world-class API manufacturing facilities close to the city of Hyderabad, capable in handling complex and hazardous reactions.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1861.70 |
Dr. Reddys Lab | 1389.35 |
Cipla | 1506.15 |
Lupin | 2228.00 |
Zydus Lifesciences | 972.70 |
View more.. |